This is a demo store. No orders will be fulfilled.
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
05 Dec 2014  |  North America  |  Market Research
US Hemostasis Market
Increase in the Number of Patients within the Healthcare System Triggers Reagent Market Growth
The Affordable Care Act has created an upswing in the number of patients entering the US healthcare system, boosting the volume of routine and specialized testing performed in laboratories. This market insight analyzes the instrumentation and reagent segment activity within the US hemostasis market. Key trends and a comparative analysis between the...
$2,450.00 -
21 Nov 2014  |  North America  |  Market Research
Analysis of the US LIMS Market
Pharmaceuticals and Biobanks Spur Market Revenue with Increasing Adoption of Thin-client Web-based Systems
The laboratory information management systems (LIMS) market in the United States has been a mature space for many years. The evolution of laboratory needs has spurred innovation in this industry, forcing vendors to change their approach toward consumers. Consumers have the option of choosing between thick-client (Web-enabled) solutions, thin-client...
$3,950.00 -
20 Nov 2014  |  North America  |  Market Research
Product and Pipeline Analysis of the Global Rheumatoid Arthritis Therapeutics Market
Launch of Novel Oral Therapies to Result in Major Market Changes
This market insight discusses the rheumatoid arthritis pharmaceutical drugs currently in the global market as well as those in the development stage. It offers a competitive analysis of the drugs and a forecast of their impact on the market. Drugs in the development stage are segmented by clinical trial phase as well as by drug class. The study cov...
$3,950.00 -
18 Nov 2014  |  North America  |  Market Research
Global Analysis of Ebola Disease
Expenditure on Prevention and Containment to Soar towards $5.9 Billion by End of 2016
This market insight provides a first-of-its-kind analysis of market sizing and revenue forecasts through 2016 for the prevalent Ebola virus. The number of people infected nears 10,000 globally, and the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) have deemed this the worst outbreak due to the death toll neari...
$2,450.00 -
15 Nov 2014  |  Asia Pacific  |  Market Research
Thailand In Vitro Diagnostics Market
Snapshot of Demand and Investment Opportunities
The report is expected to support the strategic decision makers in the In Vitro Diagnostic (IVD) market that are either planning to expand or enter Thailand. The forecast of the major segments can help the diagnostic companies decide their next five years business plan. Segments in the market include molecular diagnostics, immunochemistry, and mic...
$2,450.00 -
10 Nov 2014  |  North America  |  Market Research
A Product and Pipeline Analysis of the Multiple Sclerosis Therapeutics Market
Launch of Several Pipeline Oral Products Could Diminish the Market for Injectable Therapies
This market insight provides data for the global multiple sclerosis (MS) market. The analysis looks at MS pharmaceutical pipeline drugs that are currently in the market as well as any drugs that are in Phase III trials and pose a potential threat to competitors. It offers a competitive analysis of these drugs and the forecasted outcome and impact o...
$3,950.00 -
07 Nov 2014  |  Europe  |  Market Research
Analysis of the Advanced Visualisation Solutions Market in Western Europe
Trends and Dynamics of the 3D/4D Visualisation Solutions Market
This research service provides an in-depth analysis of the advanced visualisation solutions market in Western Europe. It analyses the revenue potential, market dynamics, and trends across several countries in the region. Revenues for the advanced visualisation solutions market have been derived after studying the dynamics of different market segmen...
$3,950.00 -
06 Nov 2014  |  North America  |  Market Research
Vital Signs - Healthcare News - The Analysts Perspective - October Issue
This issue of Vital Signs, released on November 6, 2014, discusses Immucors collaboration with Sirona Genomics, Becton Dickinsons acquisition of GenCell Biosystems, and an update on the Ebola virus.
$500.00 -
04 Nov 2014  |  North America  |  Market Research
2014 Life Sciences Outlook in Turkey
Rapid Economic Development and Healthcare Reforms Set the Stage for the Future
The diabetes diagnostics markets in the United States and Europe have been in a mature stage for many years. Growth is sustained due to the high prevalence of diabetes in both regions. The segments covered in the study are self-monitoring of blood glucose (SMBG), point-of-care testing (POCT), and lab-based HbA1c testing. The emerging market of non-...
$2,450.00 -
30 Oct 2014  |  North America  |  Market Research
A Competitive Analysis of the Global Asthma and COPD Therapeutics Market
Novel Inhaler Devices and Formulations are Impetuses for Growth
This market insight provides a first-of-its-kind analysis of market sizing and revenue forecasts through 2016 for the prevalent Ebola virus. The number of people infected nears 10,000 globally, and the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) have deemed this the worst outbreak due to the death toll neari...
$3,950.00